Challenges of antiangiogenic cancer therapy: trials and errors, and renewed hope
MÁ Medina, R Muñoz‐Ch´ puli… - Journal of cellular and …, 2007 - Wiley Online Library
• Introduction• What can we learn from the previous failures?• Signs of hope• Another turn of
the screw: a surrogate marker, at last• Future avenues for the vascular therapy of cancer …
the screw: a surrogate marker, at last• Future avenues for the vascular therapy of cancer …
[HTML][HTML] Challenges of antiangiogenic cancer therapy: trials and errors, and renewed hope
MÁ Medina, R Muñoz-Ch… - Journal of Cellular and …, 2007 - ncbi.nlm.nih.gov
Angiogenesis inhibition has been proposed as a general strategy to fight cancer. However,
in spite of the promising preclinical results, a first generation of antiangiogenic compounds …
in spite of the promising preclinical results, a first generation of antiangiogenic compounds …
Challenges of antiangiogenic cancer therapy: trials and errors, and renewed hope
MÁ Medina, R Muñoz‐Ch… - Journal of Cellular and …, 2007 - search.proquest.com
Angiogenesis inhibition has been proposed as a general strategy to fight cancer. However,
in spite of the promising preclinical results, a first generation of antiangiogenic compounds …
in spite of the promising preclinical results, a first generation of antiangiogenic compounds …
Challenges of antiangiogenic cancer therapy: trials and errors, and renewed hope
MA Medina, R Muñoz-Chápuli… - Journal of cellular …, 2007 - pubmed.ncbi.nlm.nih.gov
Angiogenesis inhibition has been proposed as a general strategy to fight cancer. However,
in spite of the promising preclinical results, a first generation of antiangiogenic compounds …
in spite of the promising preclinical results, a first generation of antiangiogenic compounds …
[PDF][PDF] Challenges of antiangiogenic cancer therapy: trials and errors, and renewed hope
MÁ Medina, R Muñoz-Chápuli, AR Quesada - J. Cell. Mol. Med, 2007 - Citeseer
Angiogenesis inhibition has been proposed as a general strategy to fight cancer. However,
in spite of the promising preclinical results, a first generation of antiangiogenic compounds …
in spite of the promising preclinical results, a first generation of antiangiogenic compounds …
Challenges of antiangiogenic cancer therapy: trials and errors, and renewed hope.
MA Medina, R Muñoz-Chápuli… - Journal of Cellular and …, 2007 - europepmc.org
Angiogenesis inhibition has been proposed as a general strategy to fight cancer. However,
in spite of the promising preclinical results, a first generation of antiangiogenic compounds …
in spite of the promising preclinical results, a first generation of antiangiogenic compounds …
Challenges of antiangiogenic cancer therapy: trials and errors, and renewed hope.
MA Medina, R Muñoz-Chápuli… - Journal of Cellular and …, 2007 - europepmc.org
Angiogenesis inhibition has been proposed as a general strategy to fight cancer. However,
in spite of the promising preclinical results, a first generation of antiangiogenic compounds …
in spite of the promising preclinical results, a first generation of antiangiogenic compounds …